BlackRock Health Sciences Trust (NYSE:BME) Shares Cross Above 50 Day Moving Average – Time to Sell?

BlackRock Health Sciences Trust (NYSE:BME) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $41.35 and traded as high as $42.35. BlackRock Health Sciences Trust shares last traded at $41.76, with a volume of 28,236 shares changing hands.

BlackRock Health Sciences Trust Price Performance

The stock has a 50 day simple moving average of $41.35 and a 200 day simple moving average of $38.80.

BlackRock Health Sciences Trust Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Friday, March 13th will be issued a dividend of $0.2621 per share. This represents a c) dividend on an annualized basis and a yield of 7.5%. The ex-dividend date is Friday, March 13th.

Institutional Trading of BlackRock Health Sciences Trust

Several institutional investors and hedge funds have recently bought and sold shares of BME. Northwestern Mutual Wealth Management Co. grew its stake in BlackRock Health Sciences Trust by 22.2% in the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after purchasing an additional 257 shares during the period. AlphaStar Capital Management LLC boosted its stake in BlackRock Health Sciences Trust by 2.2% during the fourth quarter. AlphaStar Capital Management LLC now owns 12,099 shares of the company’s stock worth $498,000 after acquiring an additional 258 shares in the last quarter. Oppenheimer & Co. Inc. increased its stake in shares of BlackRock Health Sciences Trust by 5.9% during the third quarter. Oppenheimer & Co. Inc. now owns 6,715 shares of the company’s stock valued at $250,000 after purchasing an additional 373 shares in the last quarter. SOA Wealth Advisors LLC. lifted its holdings in shares of BlackRock Health Sciences Trust by 20.3% during the third quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock valued at $103,000 after purchasing an additional 469 shares during the last quarter. Finally, Royal Bank of Canada grew its stake in shares of BlackRock Health Sciences Trust by 0.5% in the 1st quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after buying an additional 684 shares during the last quarter.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.